Infection plagues IQ?

By Richard P. Grant Infection plagues IQ? As a nation’s economy develops and its standard of living rises, the average intelligence of its inhabitants also increases. But why? In what Faculty of 1000 Member and University of Münster evolutionary biologist Joachim Kurtz calls a “thought-provoking” study, Christopher Eppig suggests that healthier inhabitants could be the answer: Infectious diseases are rarer in developed nations than they ar

Written byRichard P. Grant
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

As a nation’s economy develops and its standard of living rises, the average intelligence of its inhabitants also increases. But why? In what Faculty of 1000 Member and University of Münster evolutionary biologist Joachim Kurtz calls a “thought-provoking” study, Christopher Eppig suggests that healthier inhabitants could be the answer: Infectious diseases are rarer in developed nations than they are in the developing world, leaving their citizens with more metabolic energy available for cognitive development (Proc R Soc B, doi:10.1098/rspb.2010.0973, 2010).

Selling the Self-evident

Decoding the Brain

A New Dynamic

The intelligence quotient (IQ) test has been used around the world as a measure of cognitive ability. Although controversial, results from these tests have been used to obtain average IQ measures for a nation or geographical region. The average IQ of a country correlates with many factors: temperature, gross domestic product, secondary education, nutrition. And in a nation on its way ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies